Azenta (NASDAQ:AZTA) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Azenta (NASDAQ:AZTAGet Rating) announced its quarterly earnings results on Monday. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.11 by $0.01, MarketWatch Earnings reports. Azenta had a return on equity of 8.87% and a net margin of 14.57%. The business had revenue of $145.60 million for the quarter, compared to analyst estimates of $142.10 million. During the same quarter in the prior year, the company posted $0.61 EPS. The company’s quarterly revenue was up 12.3% on a year-over-year basis. Azenta updated its Q3 2022 guidance to $0.09-$0.17 EPS and its Q3 guidance to $0.09-0.17 EPS.

NASDAQ AZTA opened at $64.69 on Tuesday. The company has a 50 day simple moving average of $80.53. The company has a current ratio of 2.33, a quick ratio of 2.13 and a debt-to-equity ratio of 0.04. Azenta has a one year low of $64.04 and a one year high of $124.79. The stock has a market capitalization of $4.85 billion, a price-to-earnings ratio of 37.61 and a beta of 1.66.

AZTA has been the subject of several research reports. B. Riley initiated coverage on Azenta in a research report on Thursday, March 31st. They issued a “buy” rating for the company. Needham & Company LLC lowered their price objective on shares of Azenta from $155.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, February 9th. Zacks Investment Research raised shares of Azenta from a “sell” rating to a “hold” rating in a research note on Tuesday, May 3rd. Finally, Evercore ISI initiated coverage on shares of Azenta in a research note on Monday, March 21st. They issued an “outperform” rating and a $100.00 price objective for the company.

Azenta Company Profile (Get Rating)

Azenta, Inc provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates.

See Also

Earnings History for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with's FREE daily email newsletter.